Literature DB >> 9596502

Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.

C C Klaver1, R C Wolfs, J R Vingerling, A Hofman, P T de Jong.   

Abstract

OBJECTIVE: To study the prevalence and causes of blindness and visual impairment in various age categories of a large population-based study.
METHODS: For the study, 6775 subjects aged 55 years or older underwent an extensive ophthalmologic screening examination, including measurements of visual acuity and the visual field and fundus photography. The causes of blindness or visual impairment were determined using all screening information and medical records.
RESULTS: The prevalence of blindness, according to World Health Organization criteria, ranged from 0.1% in subjects aged 55 to 64 years to 3.9% in subjects aged 85 years or older; the prevalence of visual impairment ranged from 0.1% to 11.8%. For persons younger than 75 years, myopic degeneration and optic neuropathy were the most important causes of impaired vision. For persons aged 75 years or older, age-related macular degeneration was the major cause of the increased prevalence of blindness, whereas age-related cataract predominantly caused the increased prevalence of visual impairment.
CONCLUSIONS: The hierarchy of causes of blindness and visual impairment is highly determined by age. As yet, little can be done to reduce the exponential increase of blindness; however, adequate implementation of surgery to treat cataract could reduce visual impairment by one third. Underuse of ophthalmologic care is a prominent cause of the high frequency of untreated cataracts among the elderly.

Entities:  

Mesh:

Year:  1998        PMID: 9596502     DOI: 10.1001/archopht.116.5.653

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  208 in total

1.  Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study.

Authors:  E Odding; H A Valkenburg; H J Stam; A Hofman
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Decoding simulated neurodynamics predicts the perceptual consequences of age-related macular degeneration.

Authors:  Jianing V Shi; Jim Wielaard; R Theodore Smith; Paul Sajda
Journal:  J Vis       Date:  2011-12-05       Impact factor: 2.240

3.  The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit.

Authors:  M Kliffen; E Lutgens; M J Daemen; E D de Muinck; C M Mooy; P T de Jong
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

4.  Auditory confrontation naming in Alzheimer's disease.

Authors:  Jason Brandt; Arnold Bakker; David Aaron Maroof
Journal:  Clin Neuropsychol       Date:  2010-10-27       Impact factor: 3.535

5.  Macular pigment density at the site of altered fundus autofluorescence.

Authors:  Simon Paul Rothenbuehler; Ute E K Wolf-Schnurrbusch; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-28       Impact factor: 3.117

6.  A novel classification of high myopia into anterior and posterior pathologic subtypes.

Authors:  Cassie A Ludwig; Ryan A Shields; Tiffany A Chen; Matthew A Powers; D Wilkin Parke; Andrew A Moshfeghi; Darius M Moshfeghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-20       Impact factor: 3.117

7.  Myopia prevalence in Canadian school children: a pilot study.

Authors:  Mike Yang; Doerte Luensmann; Desmond Fonn; Jill Woods; Debbie Jones; Keith Gordon; Lyndon Jones
Journal:  Eye (Lond)       Date:  2018-02-02       Impact factor: 3.775

8.  The cost-utility of aflibercept for the treatment of age-related macular degeneration compared to bevacizumab and ranibizumab and the influence of model parameters.

Authors:  Mari Elshout; Margriet I van der Reis; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-29       Impact factor: 3.117

9.  Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa.

Authors:  Andrew J Lotery; Dominique Baas; Caroline Ridley; Richard P O Jones; Caroline C W Klaver; Edwin Stone; Tomoyuki Nakamura; Andrew Luff; Helen Griffiths; Tao Wang; Arthur A B Bergen; Dorothy Trump
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

10.  The significance of early treatment of exudative age-related macular degeneration: 12 months' results.

Authors:  Birgit Weingessel; Gregor Hintermayer; Saskia M Maca; Renate Rauch; Pia Veronika Vecsei-Marlovits
Journal:  Wien Klin Wochenschr       Date:  2012-10-24       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.